http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Dec 2025 07:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html <p align="justify">TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p>A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=vfxXlhBClZ6eUqgeG26-Gctxnt3ZJipBzb_JZfPdjAibPO6g-9Os4IAPhTq0taTq1n9jQ2avyYsbV_vb-XDTIOtc_Q2Vb6y53UcXka1pmkQU873YlklQQuDSuswTuaKAY0nlM17t2Rrs_UTE6xCXjO6LOKs2IzmBGTfvdJPD5unq9-JbOFbzhjOsMhL9bogRMgCJAKjp5Vdl0Rgl_fOnlA==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment as http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25767470.html Mon, 22 Dec 2025 07:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Press+Releases/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html <p align="justify">TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.</p> <p align="justify">A link to this complaint can be found <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4JVkcReZjvCFQa-xcTaGi-sTNQTbe10dI-kY52-k1rC_TaU8f_ueLWxWyaSQpzt-HxGKnE07Hy_939a90oyNUdqimPhyz7p-Wa9sF6vrJI9ouq_Y1i-R2XWSmqn2BLXWD5b00L029C-AaT7QSroFbaJZPl82lmbkA7gcKCPRleJ8YWVSdeD_vf03vFodiVRnFvaJ8KsdnQAWwEl3ERdVow==" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Quantum Biopharma intends to seek appointment http://www.streetinsider.com/Globe+Newswire/World+Renowned+Law+Firm+Grant+%26amp%3B+Eisenhofer+Files+Class+Action+Lawsuit+Against+Canadian+Banks+CIBC+and+RBC+Alleging+Illegal+Stock+Market+Manipulation+of+Quantum+BioPharma+Shares/25765586.html Fri, 19 Dec 2025 16:52:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Press+Releases/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html <p align="justify">TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“<strong>Quantum BioPharma</strong>”), is pleased to announce that national television network CTV News’ flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.</p> <p align="justify">Top CTV News journalist and W5 investigative reporter Jon Woodward describes Part One of the series in an article entitled, “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that http://www.streetinsider.com/Globe+Newswire/Quantum+Biopharma%E2%80%99s+USD+%24700+Million+Lawsuit+Alleging+Stock+Market+Manipulation+Subject+of+3-part+Series+Investigative+News+Program+W5/25662786.html Tue, 25 Nov 2025 16:00:00 -0500 0K91 O.39443675 QNTM QNTM http://www.streetinsider.com/Press+Releases/Quantum+BioPharma+Ltd.+Provides+Corporate+Update/25538965.html <p align="justify">TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K9A) (“<strong>Quantum</strong>” or the “<strong>Company</strong>”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that pursuant to the entry into its previously announced at the market offering agreement (the “<strong>ATM Agreement</strong>”) with H.C. Wainwright &amp; Co., LLC (“<strong>Wainwright</strong>”) on February 16, 2024, announces today, the Company at its discretion may offer and sell, from time to time, through Wainwright as sales agent, Class B Subordinate Voting Shares in the capital of the Company http://www.streetinsider.com/Press+Releases/Quantum+BioPharma+Ltd.+Provides+Corporate+Update/25538965.html Fri, 31 Oct 2025 19:51:00 -0500 0K91 O.39443675 QNTM QNTM